Regeneron Pharmaceuticals, Inc. (REGN) Earnings History

Quarterly EPS Results — source: SEC EDGAR
QuarterEPS EstimateEPS ActualSurpriseResult
Q22026 FY2026$8.47——Miss

Back to REGN overview · REGN holders · REGN KPIs

Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.